Headline News Archive
Click on title to read the full article.
Opinion: Battling Cancer, and FDA Bureaucrats
January 31, 2020
By Robert Goldberg
For some patients with advanced breast cancer, 2011 began with a harrowing close call: A federal contractor announced that Medicare would no longer pay for women in several states to receive treatment with the drug Avastin.
A Fighting Spirit Won’t Save Your Life
January 30, 2020
By Richard Stone Op Editor NYT
GABRIELLE GIFFORDS’S remarkable recovery from a bullet to her head has provided a heartening respite from a national calamity. Representative Giffords’s husband describes her as a “fighter,” and no doubt she is one. Whether her recovery has anything to do with a fighting spirit, however, is another matter entirely.
Do Emotions Play a Role in Illness?
January 29, 2020
By New York Times Letters to the Editor
Support groups prolong survival in women with metastatic breast cancer.
Abrupt Turnabout in Fortunes of PARP Inhibitor
January 28, 2020
By Charles Bankhead
A highly touted investigational breast cancer therapy failed to extend survival in women with metastatic triple-negative disease, according to final results from a large phase III trial.
Vinorelbine 'Preferred' Chemo in HER2-Positive Advanced Breast Cancer
January 28, 2020
By Nick Mulcahy
What's the best chemotherapy to use in combination with trastuzumab in women with HER2-positive metastatic and locally advanced breast cancer?
"Race for the Cure" brand battle courts controversy
January 27, 2021
By Anne Thompson, NBC Nightly News
Susan G Komen Race for the Cure, one of the country's largest and best funded breast cancer charities, is being questioned about its agressive tactics when it comes to protecting its trademark.
ASCO GI: Rethink Views On Breast CA Liver Mets
January 24, 2021
By Charles Bankhead
Resection of breast cancer liver metastases paid off in a survival benefit in patients with chemotherapy-responsive, estrogen receptor (ER)-positive primary tumors, according to data from a retrospective chart review.
Eisai's Halaven(TM) (Eribulin) Receives CHMP Positive Opinion for use in Metastatic Breast Cancer
January 21, 2021
By PR Newswire
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), today gave a positive opinion for the use of Eisai Europe, Ltd.'s Halaven as a monotherapy indicated in the treatment of patients with locally advanced (LA) or metastatic breast cancer (MBC) who have progressed after at least two chemotherapeutic regimens for advanced disease.
Bevacizumab in Breast Cancer: Genentech Submits Response to FDA
January 20, 2021
By Zosia Chustecka
Genentech, the manufacturer of bevacizumab (Avastin), submitted a response to the US Food and Drug Administration (FDA) today on the agency's proposal to withdraw the drug's breast cancer indication.
A Pink-Ribbon Race, Years Long
January 18, 2021
By Roni Caryn Rabin, New York Times
By the time Suzanne Hebert realized that her doctor was wrong and that the hard lump in her breast wasn’t a normal part of breast-feeding, the tumor was the size of a stopwatch and the cancer had spread to her spine.
Headline News Archive
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- October 2007
- September 2007